CATABASIS PHARMACEUTICALS INC
Profile
Company Names
CATABASIS PHARMACEUTICALS INC
Addresses
100 HIGH STREET, 28TH FLOOR, BOSTON, MA 02110
ONE KENDALL SQUARE, BLDG. 1400E, SUITE 14202, CAMBRIDGE, MA 02139
ONE KENDALL SQUARE, BLDG. 1400E, SUITE B14202, CAMBRIDGE, MA 02139
161 FIRST STREET, SUITE 1A, CAMBRIDGE, MA 02142
19 BLACKSTONE STREET, CAMBRIDGE, MA 02139
Phone Numbers
617-349-1971
617-349-1970
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2008
State Incorporated:
DELAWARE
Total Amount Raised:
$349,622,627.00
Number of Funding Rounds:
7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2021-02-01
$110,010,570.00
$110,010,570.00
$0.00
Equity
6
2021-01-28
$175,738,599.00
$175,738,599.00
$0.00
Equity
5
2015-03-17
$12,413,736.00
$20,358,737.00
$7,945,001.00
Equity
4
2013-10-31
$32,433,331.00
$32,433,331.00
$0.00
Equity
3
2013-01-18
$9,195,865.00
$9,195,865.00
$0.00
Equity
2
2010-04-07
$7,740,526.00
$39,740,526.00
$32,000,000.00
Equity
1
2008-12-31
$2,090,000.00
$3,000,000.00
$910,000.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRED
CALLORI
DIRECTOR
NICHOLAS
GALAKATOS
DIRECTOR
AFFYMAX INC
| PORTOLA PHARMACEUTICALS INC
| AVEO PHARMACEUTICALS INC
| TALIGEN THERAPEUTICS INC
| OPHTHOTECH CORP.
| NANOSTRING TECHNOLOGIES INC
| CATABASIS PHARMACEUTICALS INC
| CLARUS LIFESCIENCES III, L.P.
| CLARUS DEFINED EXIT I, L.P.
| CLARUS DE II, L.P.
| CLARUS IV-D, L.P.
| CLARUS IV-C, L.P.
| CLARUS IV-B, L.P.
| CLARUS IV-A, L.P.
| PRAXIS PRECISION MEDICINES, INC.
| BLACKSTONE LIFE SCIENCES YIELD NT (CYM) FEEDER L.L.C.
| BLACKSTONE LIFE SCIENCES YIELD L.P.
| BLACKSTONE LIFE SCIENCES YIELD T (CYM) FEEDER L.P.
| BLACKSTONE LIFE SCIENCES VI L.P.
| BLACKSTONE LIFE SCIENCES VI (LUX) SCSP
| BLACKSTONE LIFE SCIENCES VI - BL L.P.
| BLACKSTONE LIFE SCIENCES VI - B L.P.
JEAN
GEORGE
DIRECTOR
RON
LAUFER
DIRECTOR
JEFFREY
LEIDEN
DIRECTOR
ANDREW
NICHOLS
EXECUTIVE OFFICER
MICHAEL
ROSS
DIRECTOR
CERVILENZ INC
| JUVARIS BIO THERAPEUTICS INC
| IKANO THERAPEUTICS INC.
| ADIMAB, INC.
| SV LIFE SCIENCES FUND V LP
| LINK MEDICINE CORP
| CATABASIS PHARMACEUTICALS INC
| SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.
| ARSANIS, INC.
| BALANCE HEALTH CORP
| ABCAM PLC
| ADIMAB, LLC
| AVITIDE, INC.
| OPHTHOTECH CORP.
| THESAN PHARMACEUTICALS, INC.
| SV LIFE SCIENCES FUND VI, L.P.
| DECIPHERA PHARMACEUTICALS, LLC
| DEMENTIA DISCOVERY LP
| AMERICLEAN HOLDINGS LLC
| SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.
| FRESCO FOODS, INC.
| SUTRO BIOPHARMA INC
| RIBOMETRIX, INC.
| JASON RYAN
| NICE RECOVERY SYSTEMS LLC
| THERINI BIO, INC.
| MAINE CRISP COMPANY, LLC
| JOSEPH VENTURES ALLIUM I LLC, SERIES A
| XILIO THERAPEUTICS, INC.
| JOSEPH VENTURES ALLIUM I LLC, SERIES C
| SV LIFE SCIENCES FUND IV CF, L.P.
| ANDOVIA INC.
| TREX HOLDINGS INC.
| DUALITAS THERAPEUTICS, INC.
CHRIS
THOMAJAN
EXECUTIVE OFFICER
JONATHAN
VIOLIN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-01-28
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-02-01
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-03-17
